Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Idaho for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Idaho only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Idaho (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Svetlana Meier (NPI 1609054659)

Field	Value
Entity Type	Individual
Organization	Svetlana Meier
Address	3277 E Louise Dr
City	Meridian
State	ID
ZIP	83642
Taxonomy	Rheumatology Physician
NPI Enumerated	February 1, 2008

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

SVETLANA MEIER’s Medicare practice is heavily focused on physician-administered biologic and infusion therapies consistent with rheumatology specialty care; the top revenue codes are J3111, J3262 and J0129, and the precomputed top-3 Medicare codes account for 62.9% of the provider’s total Medicare revenue, indicating the business model centers on high-cost injected biologics and infusion services rather than high-volume evaluation-and-management visits.

Medicare revenue for this provider totals $2.5M while there is no Medicaid billing on file, making the practice effectively single-payer in the available data and reliant entirely on Medicare for documented public-payer revenue. This concentration exposes the provider to Medicare reimbursement dynamics for infused and injected specialty drugs.

J3111 (romosozumab) is the single largest Medicare revenue driver at $707.3K (28.2% of Medicare revenue) and the provider ranks #20 of 970 nationally (98th percentile), which makes this provider a high-volume national outlier for that specific drug compared with peers and suggests substantial romosozumab administration in their case mix.

J3262 (tocilizumab) contributes $540K (21.5% of Medicare revenue) and the provider ranks #41 of 618 nationally (94th percentile), marking another above-typical national volume code; together with J3111 these two biologic codes generate a large share of revenue and reinforce the practice’s emphasis on in-office administration of costly specialty injectables.

J0129 (abatacept) accounts for $330K (13.2% of Medicare revenue) and ranks #478 of 1221 nationally (61st percentile), a middle-of-distribution position that is unremarkable compared to peers — this suggests a mix of both extremely high-volume biologic administrations (for some drugs) and more typical volumes for others.

Several infusion- and injection-related procedural codes also appear at unusually high national percentiles: J1745 ranks in the 94th percentile and 96365 ranks in the 96th percentile, while 96372 is an extreme outlier at the 99th percentile. Those patterns indicate that beyond specific branded biologics, the provider conducts a high volume of infusion and injection encounters relative to national rheumatology peers.

Evaluation-and-management visits (99214, 99213) represent only a small share of Medicare revenue ($37.7K and $3.2K respectively) and have mixed percentile standings; 99214 is at the 87th percentile while 99213 is at the 38th percentile. This suggests the practice generates most revenue from drug administration rather than routine office visit volume and may operate a clinic model oriented to infusion sessions.

With an NPI enumerated around 2008-02-01 (~18 years ago), the provider has long tenure in the Medicare program, which supports sustained patterns of specialty drug administration over time rather than a transient billing profile. This extended enrollment combined with the concentration in high-cost injectables positions the provider as an established infusion-based rheumatology practice in Medicare data.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

44 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3111	Injection, romosozumab-aqqg, 1 mg	88,410	$10	$707.3K
J3262	Injection, tocilizumab, 1 mg	108,000	$10	$540K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	10,000	$30	$330K
J1602	Injection, golimumab, 1 mg, for intravenous use	32,550	$10	$325.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	10,520	$30	$273.5K
J0897	Injection, denosumab, 1 mg	8,640	$20	$155.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	440	$90	$37.7K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	550	$40	$23.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	250	$90	$20.8K
76881	In this procedure, the provider uses ultrasound to examine the complete joint for any defect or abnormality. The image appears in real time on a monitor, and a permanent image with interpretation is…	340	$40	$12.7K

Showing 1–10 of 44

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 44 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Idaho Distribution

Svetlana Meier — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Idaho

Full comparison — all codes billed, vs. state median

44 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	4	10	9,950	$30	$369.8K
J3262	2	10	27,790	$1	$340.8K
J3111	1	10	23,420	$10	$295.7K
J1602	2	10	15,030	$10	$266.6K
J1745	2	10	8,420	$30	$196.9K
J0897	4	30	2,580	$20	$76.2K
96413	8	20	250	$90	$26K
99214	193	2,690	90	$70	$10.4K
96365	2	20	80	$40	$7.4K
86235	5	10	310	$20	$6.2K

Showing 1–10 of 44

Related Providers

Other providers that share a Tax Identification Number (TIN) with Svetlana Meier, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mikael Lagwinski	ID	Rheumatology Physician	$2.2M	$0
Eric Palfreyman	OH	Internal Medicine Physician	$1M	$0
Rebecca Privon	MS	Registered Nurse	$62.4K	$0
Camille Buchmiller	ID	Physician Assistant	$61.5K	$0
Kyle George	ID	Medical Physician Assistant	$49.1K	$0
Colette Weber	ID	Physician Assistant	$26.1K	$0

Nearby Providers

Other providers in the same ZIP code as Svetlana Meier, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Norco, Inc.	ID	Durable Medical Equipment & Medical Supplies	$0	$41M
Joint School District No. 2	ID	Local Education Agency (LEA)	$0	$34.2M
Chatterbox Speech & Language Center	ID	Speech-Language Pathologist	$0	$10.6M
St. Fillan's, LLC	ID	In Home Supportive Care Agency	$0	$10.5M
Southern Idaho Health Partners LLC	ID	General Practice Physician	$0	$9.2M
Gem State Developmental Center LLC	ID	Developmentally Disabled Services Day Training Agency	$0	$9.1M
Addus Healthcare, Inc.	ID	In Home Supportive Care Agency	$0	$6.1M
Northwest Neurobehavioral Health, LLC	ID	Clinical Social Worker	$0	$5.2M
Idaho Pediatric Therapy Clinic PLLC	ID	Physical Therapist	$0	$3.1M
Cpapnow Inc	ID	Durable Medical Equipment & Medical Supplies	$0	$3.1M

Svetlana Meier — Billing Profile & Reimbursement Data

Sign up for Svetlana Meier — Billing Profile & Reimbursement Data policy alerts

Svetlana Meier — Billing Profile & Reimbursement Data

Sign up for Svetlana Meier — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References